ALFA Finder| Revenue growth | 13.3% YoY growth to INR 2,315 Mn. |
|---|---|
| Margins | EBITDA margin expanded 584 Bps YoY to 17.97%. |
| Demand visibility | Strong recovery in last six quarters. |
| Management confidence | High; citing full recovery from H1 FY26 trough. |
Growth
Revenue grew 13.3% YoY to INR 2,315 Mn; PAT jumped 257% YoY to INR 293 Mn.
Outlook
Focus on specialty chemicals, backward integration, and zero liquid discharge plants. Total production capacity at 70,000 TPA.
Risks
Historical revenue volatility and prior period step-down subsidiary dilution impact comparability; sensitivity to chemical cycles.
Investor Presentation filed with BSE, NSE: VALIANTORG. Summary written with AI assistance from the document.
Valiant Organics Ltd: key numbers
- Share price
- ₹361.15
- Market cap
- ₹1,012 Cr
- Revenue (annual)
- ₹738.8 Cr
- Net profit (annual)
- ₹33.24 Cr
- P/E (TTM)
- 15.4×Sector 35.5×
- Promoter holding
- 37.89%+0.02% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Organics Ltd
All →Valiant Organics Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 203.5% YoY
Valiant Organics Ltd reported revenue from operations of ₹304.2 Cr (+93.4% YoY) and net profit of ₹17.3 Cr (+203.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +203.5% YoY
Valiant Organics Board Meeting Date
Valiant Organics schedules a board meeting on November 5, 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until November 7, 2026.
Valiant Organics Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Valiant Organics Legal & Regulatory
Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.
- Value
- ₹0.22 Cr
Valiant Organics Investor Presentation: Key Takeaways
Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics Annual General Meeting
Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.